On October 10, 2020, Dr. Phillips and Dana Parish led a discussion about the topics in their upcoming book, “Chronic: The Hidden Cause of Autoimmune Pandemic and How to Get Healthy Again” at the 5th Annual LymeMIND Virtual Conference. Check out the full event schedule at lymemind.org/agenda
The LymeMIND team, based at the Icahn School of Medicine at Mount Sinai, is made up of diverse experts in the areas of computational biology, epidemiology, software engineering, systems biology, and Lyme disease research.
Lyme disease patients fight for their lives while academics fight each other. That’s just wrong.
The number of people who get Lyme disease compared to how little research on it is ever funded is staggering. Scientific bias is hurting people.
For patients, there is often nothing more soul-crushing than being inexplicably sick with doctor after doctor having no answers, or getting the wrong diagnosis and being led down the wrong path with the wrong drugs. But for patients with Lyme disease, either or both is common, because its every aspect has been so bitterly contested by scientists that the conversation has been sourly referred to as “The Lyme Wars” in medical journals.
Linked below is the piece Dr. Phillips wrote, which was published in Norway’s largest newspaper, Aftenposten meninger (it can be translated from Norwegian to English on google translate). It was written in response to a piece by a Norwegian doctor, who makes a series of incorrect claims, including that chronic Lyme is as a pseudo-diagnosis and that researchers who have found evidence supporting chronic Lyme are pseudo-scientific.
This $100,000 scientific grant has allowed us to go forward with the much needed initial proof of concept testing of our new drug to combat Lyme and bartonella and research is underway. Bay Area Lyme Foundation is an amazing organization and we couldn’t be more grateful! I’m working alongside Dr. Neil Spector of Duke University, Dr. Jayakumar Rajadas of Stanford University, Dr. Ed Breitschwerdt and his team from Galaxy Diagnostics and NC State, Dana Parish, and too many others to list here. We’re developing a drug for the treatment of bartonella and Lyme, made possible by this joint-development effort involving some of the smartest folks from academia, the private sector, and the non-profit world.
Joint venture between Duke University, Johns Hopkins University, and Tulane University. This project was fully funded by the Steven and Alexandra Cohen Foundation, which is a stellar organization. The goal is to use a specialized high-throughput proteomics platform to find new drugs to treat Lyme and Bartonella. It’s the same precision medicine technology used to find drugs for cancer and HIV, only this time it’s finally turned toward eradicating Lyme and Bartonella. The advantage of this type of research is that it results in highly specific, smart bombs that keenly target these organisms but do not destroy beneficial microbes, for example in our GI tract. At the same time, we can engineer the results so as to minimize any harm to human cells. We already have lots of drug candidates and have now moved past the initial steps.